Article
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
British journal of cancer - 1 May 2021
Halle Mari K, Sødal Marte, Forsse David, Engerud Hilde, Woie Kathrine, Lura Njål G, Wagner-Larsen Kari S, Trovik Jone, Bertelsen Bjørn I, Haldorsen Ingfrid S, Ojesina Akinyemi I, Krakstad Camilla
Abstract excerpt
BACKGROUND: Advanced cervical cancer carries a particularly poor prognosis, and few treatment options exist. Identification of effective molecular markers is vital to improve the individualisation of treatment. We investigated transcriptional data from cervical carcinomas related to patient survival and recurrence to identify potential molecular drivers for aggressive disease. METHODS: Primary tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
